HAMPTON ROADS, VA— One in eight women in the U.S. will be diagnosed with breast cancer during their lifetime. For many, this diagnosis is just the beginning—up to 30% of early-stage breast cancer cases may later progress to metastatic disease. As treatment options continue to evolve, understanding the specifics of your cancer has never been more critical. One important factor to consider is your tumor’s HER2 status.
Coast spoke with internationally renowned oncologist, Dr. Edith Perez, and Cancer advocate, Lauren, about HER2.
Presented by: Daiichi Sankyo and AstraZeneca
